GHRH analog is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-04-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
The United States detonated an experimental device in the 1955 Operation Teapot "MET" test which used a plutonium/233U composite pit; its design was based on the plutonium/235U pit from the TX-7E, a prototype Mark 7 nuclear bomb design used in the 1951 Operation Buster-Jangle "Easy" test. Although not an outright fizzle, MET's actual yield of 22 kilotons was sufficiently below the predicted 33 kt that the information gathered was of limited value. The United States conducted several additional weapons tests with 233U for unknown purposes. The Soviet Union detonated its first hydrogen bomb the same year, the RDS-37, which contained a fissile core of 235U and 233U. In 1998, as part of its Pokhran-II tests, India detonated an experimental 233U device of low-yield (0.2 kt) called Shakti V. The B Reactor and others at the Hanford Site optimized for the production of weapons-grade material have been used to manufacture 233U. The United States Atomic Energy Commission used the weapons production reactors at Hanford to breed significant quantities of 233U from thorium for use in both nuclear weapons and for civilian research. Overall the United States is thought to have produced two tons of 233U, of various levels of purity, some with 232U impurity content as low as 6 ppm. The hazards are significant even at 5 parts per million. Implosion nuclear weapons require 232U levels below 50 ppm (above which the 233U is considered "low grade"; cf.
=== Approaches === Psychiatric illnesses can be conceptualised in several different ways. The biomedical approach examines signs and symptoms and compares them with diagnostic criteria. Mental illness can be assessed, conversely, through a narrative which tries to incorporate symptoms into a meaningful life history and to frame them as responses to external conditions. For example, the Power Threat Meaning Framework (PTMF) is a conceptual approach to understanding mental distress that serves as an alternative to traditional psychiatric diagnostic systems. Rather than viewing distress primarily as a symptom of an underlying mental disorder, the framework emphasizes the role of adversity, trauma, social inequalities, relationships, and cultural contexts in shaping people's experiences, and proposes that many forms of distress can be understood as meaningful responses to difficult circumstances. Both approaches are considered important in the field of psychiatry, but have not sufficiently reconciled to settle controversy over either the selection of a psychiatric paradigm or the specification of psychopathology. The biopsychosocial model is used to explain the multifactorial origins of clinical impairment, recognizing that biological, psychological, and social factors all play a role in health and disease. Once a medical professional diagnoses a patient there are numerous ways that they could choose to treat the patient. Often psychiatrists will develop a treatment strategy that incorporates different facets of different approaches into one.
=== Notable faculty === Emily Anderson - first professor of German Nicholas Canny - historian Colm McDonald - professor of psychiatry Michael D. Higgins - sociologist, 9th President of Ireland William King - geologist Alice Perry - engineer Gerard Quinn - jurist, specialist in international and comparative disability law and policy Niamh Reilly - sociologist and political scientist George Johnstone Stoney - physicist
The term poison is often used colloquially to describe any harmful substance, especially corrosive substances, carcinogens, mutagens, teratogens, and harmful pollutants. In everyday language, it is sometimes used to exaggerate the perceived danger of certain chemicals. The 16th-century physician Paracelsus (1493–1541), regarded as the father of toxicology, famously stated: "Everything is poison, there is poison in everything. Only the dose makes a thing not a poison." (See: LD50). The term is also used in a figurative sense—for example: "His brother's presence poisoned the atmosphere at the party." In contrast, legal definitions of "poison" tend to be narrower. Some substances that are not legally required to carry a "poison" label may still cause medical conditions associated with poisoning. Some poisons are also classified as toxins, which are toxic substances produced by living organisms. Examples include bacterial proteins responsible for conditions such as tetanus and botulism. While a distinction exists between "poison" and "toxin", the terms are often used interchangeably, even in scientific contexts. Related adjectives include toxic and poisonous, which are generally considered synonymous. Poisonous substances introduced into the body by sting or bite are known as venoms. In everyday usage, a poisonous organism is one that causes harm when ingested or touched, while a venomous organism uses venom actively to incapacitate prey or deter predators. Although rare, some organisms may be both poisonous and venomous.
Sources: en.wikipedia.org
In this process, the superoxide anion is produced as a by-product of several steps in the electron transport chain. Particularly important is the reduction of coenzyme Q in complex III, since a highly reactive free radical is formed as an intermediate (Q·−). This unstable intermediate can lead to electron "leakage", when electrons jump directly to oxygen and form the superoxide anion, instead of moving through the normal series of well-controlled reactions of the electron transport chain. Peroxide is also produced from the oxidation of reduced flavoproteins, such as complex I. However, although these enzymes can produce oxidants, the relative importance of the electron transfer chain to other processes that generate peroxide is unclear. In plants, algae, and cyanobacteria, ROS are also produced during photosynthesis, particularly under conditions of high light intensity. This effect is partly offset by the involvement of carotenoids in photoinhibition, and in algae and cyanobacteria, by large amounts of iodide and selenium, which involves these antioxidants reacting with over-reduced forms of the photosynthetic reaction centres to prevent the production of ROS.
=== Low blood calcium === 10% calcium gluconate solution (given intravenously) is the form of calcium most widely used in the treatment of acute and/or severe low blood calcium. Unless calcium gluconate is not available, calcium chloride is generally not recommended as a substitute. This is because the calcium chloride is more likely to cause tissue damage if the IV becomes dislodged during the infusion.
=== Circulatory and gas exchange system === The body cavity contains the circulatory or haemal system. The vessels form three rings: one around the mouth (the hyponeural haemal ring), another around the digestive system (the gastric ring), and the third near the aboral surface (the genital ring). The heart beats about six times a minute and is at the apex of a vertical channel (the axial vessel) that connects the three rings. Blood does not contain a pigment such as heme, but is probably used to transport nutrients around the body. Gas exchange mainly takes place through gills known as papulae, which are thin-walled bulges along the aboral surface of the arms. Oxygen is transferred from these to the coelomic fluid, which moves gas around the body.
Sources: en.wikipedia.org
In November 2025, federal prosecutors in Washington, D.C., opened a criminal investigation into Jerome H. Powell, the Chair of the Federal Reserve, concerning the renovation of the Federal Reserve’s headquarters and whether Powell made false or misleading statements to Congress about the scope and cost of the project. The inquiry, approved by U.S. Attorney Jeanine Pirro, involves a review of Powell’s congressional testimony and an examination of internal spending and planning records related to the renovation. The investigation marks a significant escalation in the long-running conflict between President Donald Trump and Powell, whom Trump has repeatedly criticized for resisting pressure to sharply cut interest rates. Trump has publicly accused Powell of “incompetence,” threatened to remove him from office, and raised the prospect of legal action tied to the renovation project. As of April 2026, Powell has not been charged with any crime. The Department of Justice dropped the investigation on April 24, 2026.
RCH=CH2 + H2 → RCH2−CH3 (R = alkyl) Another route to alkanes is hydrogenolysis, which entails cleavage of C-heteroatom bonds using hydrogen. In industry, the main substrates are organonitrogen and organosulfur impurities, i.e. the heteroatoms are N and S. The specific processes are called hydrodenitrification and hydrodesulfurization:
The US senior defense official Jed Babbin, Yale University professor David Gelernter, Firstpost editor R. Jagannathan, Subhash Kapila of the South Asia Analysis Group, and former Australian Prime Minister Kevin Rudd, among other sources, have used the term (occasionally using the term "Pacific Cold War") to refer to tensions between the United States and China, along with Eastern allies North Korea and Russia with Western allies Taiwan, South Korea, Japan, the Philippines and Australia, in the 2000s up until the present day.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.